Benitec Biopharma Ltd ADR (BNTC)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. Jerel A. Banks Ph.D., M.D.
Employees:
3940 Trust Way Hayward, CA 94545
510-780-0819

Benitec Biopharma, Inc., a development-stage biotechnology company, focuses on the advancement of novel genetic medicines.

Data derived from most recent annual or quarterly report
Market Cap 9.675 Million Shares Outstanding8.172 Million Avg 30-day Volume 24.342 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.62
Price to Revenue411.7275 Debt to Equity0.0 EBITDA-18.9 Million
Price to Book Value1.9758 Operating Margin-33276.9231 Enterprise Value9.081 Million
Current Ratio5.11 EPS Growth0.266 Quick Ratio4.973
1 Yr BETA 1.1443 52-week High/Low 5.07 / 1.06 Profit Margin-34188.4615
Operating Cash Flow Growth-53.8333 Altman Z-Score-13.6182 Free Cash Flow to Firm -10.005 Million
View SEC Filings from BNTC instead.

View recent insider trading info

Funds Holding BNTC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BNTC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BUCHI J KEVIN

  • Director
12,000 2021-12-08 1

SMITH EDWARD F

  • Director
12,000 2021-12-08 1

FRANCIS PETER

  • Director
12,000 2021-12-08 1

OLIVEIRA STEVEN MICHAEL

  • 10% Owner
1,000,000 2021-04-28 0

BOSTON MEGAN EXECUTIVE DIRECTOR

  • Officer
  • Director
0 2020-12-09 0

BANKS JEREL A. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-12-09 0

NANT CAPITAL, LLC

SOON-SHIONG PATRICK

CALIFORNIA CAPITAL EQUITY, LLC

  • 10% Owner
293,058 2020-04-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BENITEC BIOPHARMA INC BNTC 2022-05-16 16:45:03 UTC -19.1223 19.9423 150000
BENITEC BIOPHARMA INC BNTC 2022-05-16 16:15:03 UTC -19.1223 19.9423 150000
BENITEC BIOPHARMA INC BNTC 2022-05-16 15:45:03 UTC -19.1223 19.9423 150000
BENITEC BIOPHARMA INC BNTC 2022-05-16 15:15:03 UTC -19.1223 19.9423 150000
BENITEC BIOPHARMA INC BNTC 2022-05-16 14:45:03 UTC -19.1223 19.9423 150000
BENITEC BIOPHARMA INC BNTC 2022-05-16 14:15:03 UTC -19.1223 19.9423 150000
BENITEC BIOPHARMA INC BNTC 2022-05-16 13:45:04 UTC -19.1223 19.9423 150000
BENITEC BIOPHARMA INC BNTC 2022-05-16 13:15:03 UTC -19.1223 19.9423 150000
BENITEC BIOPHARMA INC BNTC 2022-05-16 12:45:04 UTC -19.1223 19.9423 150000
BENITEC BIOPHARMA INC BNTC 2022-05-13 22:15:03 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 21:45:03 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 21:15:03 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 20:45:03 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 20:15:03 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 19:45:04 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 19:15:03 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 18:45:03 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 18:15:03 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 17:45:03 UTC -19.1223 19.9423 75000
BENITEC BIOPHARMA INC BNTC 2022-05-13 17:15:03 UTC -19.1223 19.9423 75000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments